While the global life sciences market is not immune to the challenges facing many other industries, including growing competition and supply chain disruptions, the numbers show that it remains one of the strongest commercial real estate asset classes.

The global life sciences market was estimated to be worth more than $27B in 2022 and is predicted to reach $47.5B by 2027. As the market continues to grow, life sciences companies will need more spaces across the globe to grow along with it. This is where companies like Longfellow Real Estate Partners come in.

Longfellow has an extensive history of working with world-renowned institutions and companies in competitive life sciences markets. Now, the company is expanding its presence in the UK while continuing to take on more life sciences projects across the U.S. Longfellow sponsored Bisnow’s two-day International Life Sciences and Biotech Conference, where attendees from the company had an opportunity to connect with other major players in this booming industry and share their vision.

Bisnow spoke with several members of the Longfellow team, including Longfellow CEO and co-founder Adam Sichol and Longfellow Associate Director of ESG Lauren Ballou, for a series of articles about the company’s plans, its growing commitment to sustainability and where it sees the market heading.